Managed Care Accountability Set Quality Measures
Gold Coast Health Plan (GCHP) monitors and reports the Managed Care Accountability Set (MCAS) performance measures to assess and improve clinical quality of care. MCAS is based on the Centers for Medicare and Medicaid Services Child and Adult Core Set Measures, which includes NCQA HEDIS® measures. All state Medi-Cal Managed Care Plans are required to annually report these measures to the state Department of Health Care Services (DHCS).
MCAS Reference Materials
To help providers understand the MCAS performance measure requirements, GCHP’s Quality Improvement Department has developed a reference guide and tip sheets to share key information on individual MCAS measures. These tip sheets are not intended to direct clinical judgment, but to serve as resources in understanding measure specifications while providing guidance for measure compliance.
MCAS Tip Sheets
Download the complete 2023 MCAS Tip Sheet Reference Guide
- Adults' Access to Preventative / Ambulatory Health Services (AAP)
- Follow-up Care for Children Prescribed Attention-Deficit / Hyperactivity Disorder (ADHD) Medication (ADD)
- Antidepressant Medication Management (AMM)
- Asthma Medication Ratio (AMR)
- Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM)
- Breast Cancer Screening (BCS)
- Controlling High Blood Pressure (CBP)
- Contraceptive Care Postpartum Women Ages 15-44 (CCP)
- Cervical Cancer Screening (CCS)
- Contraceptive Care – All Women Ages 15-44 (CCW)
- Chlamydia Screening in Women Ages 16-24 (CHL)
- Childhood Immunization Status – Combo 10 (CIS-10)
- Colorectal Cancer Screening (COL)
- Developmental Screening in the First Three Years of Life (DEV)
- Depression Remission or Response for Adolescents and Adults (DRR-E)
- Depression Screening and Follow-Up for Adolescents and Adults (DSF-E)
- Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA)
- Follow-Up After Emergency Department Visit for Mental Illness (FUM)
- Hemoglobin A1c Control for Patients With Diabetes (HBD)
- Immunizations for Adolescents (IMA)
- Lead Screening in Children (LSC)
- Nulliparous Women With a Term, Singleton Baby in a Vertex Position Delivered by Cesarean Birth (NTSV)
- Pharmacotherapy for Opioid Use Disorder (POD)
- Postpartum Depression Screening and Follow-Up (PDS-E)
- Prenatal and Postpartum Care (PPC)
- Prenatal Depression Screening and Follow-Up (PND-E)
- Prenatal Immunization Status (PRS-E)
- Diabetic Screening for People with Schizophrenia of Bipolar Disorder who are using Antipsychotic Medication (SSD)
- Topical Fluoride for Children (TFL)
- Well-Child Visits in the First 30 Months of Life (W30)
- Child and Adolescent Well-Care Visits (WCV)